These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 17356196)

  • 1. Cerebral correlates of hyponatremia.
    Nathan BR
    Neurocrit Care; 2007; 6(1):72-8. PubMed ID: 17356196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin antagonism: potential impact on neurologic disease.
    Rabinstein AA
    Clin Neuropharmacol; 2006; 29(2):87-93. PubMed ID: 16614541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasopressin antagonists in treatment of hyponatremia].
    Olszewski W; Głuszek J
    Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V; Agarwal M; Joshi SR; Ghosh AK
    J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
    Verbalis JG
    Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S24-33. PubMed ID: 16970150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review: the use of vaptans in clinical endocrinology.
    Peri A
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyponatremia: role of vaptans].
    Hensen J
    Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis.
    Meena AK; Nanda PM; Sharma R; Chakrabarty B; Gulati S
    Indian J Pediatr; 2024 Feb; 91(2):188-190. PubMed ID: 36757652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
    Potts MB; DeGiacomo AF; Deragopian L; Blevins LS
    Neurosurgery; 2011 Aug; 69(2):268-73. PubMed ID: 21792136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options.
    Siragy HM
    Endocr Pract; 2006; 12(4):446-57. PubMed ID: 16901803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia in neurologic patients: consequences and approaches to treatment.
    Diringer MN; Zazulia AR
    Neurologist; 2006 May; 12(3):117-26. PubMed ID: 16688013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A; Giuliani C
    Minerva Endocrinol; 2014 Mar; 39(1):33-41. PubMed ID: 24513602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New agents for managing hyponatremia in hospitalized patients.
    Munger MA
    Am J Health Syst Pharm; 2007 Feb; 64(3):253-65. PubMed ID: 17244874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of hyponatremia in cancer patients.
    Raftopoulos H
    Support Care Cancer; 2007 Dec; 15(12):1341-7. PubMed ID: 17701059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
    Vaghasiya RP; DeVita MV; Michelis MF
    Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.